SkinHealth Systems Inc. (SKIN)
| Market Cap | 84.24M -32.5% |
| Revenue (ttm) | 296.12M -8.2% |
| Net Income | -6.54M |
| EPS | -0.15 |
| Shares Out | 129.60M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,492,783 |
| Open | 0.6201 |
| Previous Close | 0.5800 |
| Day's Range | 0.5506 - 0.6844 |
| 52-Week Range | 0.5506 - 2.6900 |
| Beta | 1.12 |
| Analysts | Buy |
| Price Target | 1.90 (+192.31%) |
| Earnings Date | May 7, 2026 |
About SKIN
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company’s flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer’s preferences to create a more personalized experience; consuma... [Read more]
Financial Performance
In 2025, SkinHealth Systems's revenue was $300.79 million, a decrease of -10.02% compared to the previous year's $334.29 million. Losses were -$9.52 million, -67.29% less than in 2024.
Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for SKIN stock is "Buy." The 12-month stock price target is $1.9, which is an increase of 192.31% from the latest price.
News
SkinHealth Systems Earnings Call Transcript: Q1 2026
Q1 sales declined 6.7% year-over-year to $64.9M, but adjusted EBITDA rose 17% to $8.5M, exceeding guidance. Full-year revenue outlook was lowered to $280M-$295M due to ongoing device demand softness, while EBITDA guidance was maintained, reflecting margin strength and operational discipline.
SkinHealth Systems Reports First Quarter 2026 Financial Results
LONG BEACH, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ: SKIN) (“SkinHealth Systems” or the "Company"), home to flagship brand Hydrafacial, today announced financial resul...
Beauty Health price target lowered to $1 from $1.50 at Canaccord
Canaccord lowered the firm’s price target on Beauty Health (SKIN) to $1 from $1.50 and keeps a Hold rating on the shares. The firm updated its model ahead of earnings…
SkinHealth Systems to Report First Quarter 2026 Financial Results on May 7, 2026
LONG BEACH, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (formerly The Beauty Health Company; Nasdaq: SKIN), a global medical aesthetics company, today announced it will report f...
SkinHealth Systems Inc. Appoints Three New Independent Directors to Board
LONG BEACH, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (formerly The Beauty Health Company; Nasdaq: SKIN), a global medical aesthetics company, today announced the appointment ...
Beauty Health rebrands to SkinHealth Systems
Beauty Health (SKIN) Company announced a corporate rebrand to SkinHealth Systems, marking its evolution into a clinically driven, science-backed medical aesthetics company. The company will operate un...
The Beauty Health Company Announces Corporate Rebrand to SkinHealth Systems, Reflecting Evolution into a Clinically Driven, Science-Backed Medical Aesthetics Platform
LONG BEACH, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ: SKIN) today announced a corporate rebrand to SkinHealth Systems Inc., marking its evolution into a clinically ...
Beauty Health price target lowered to $1.50 from $1.65 at TD Cowen
TD Cowen lowered the firm’s price target on Beauty Health (SKIN) to $1.50 from $1.65 and keeps a Hold rating on the shares. The firm updated it model following Q4…
SkinHealth Systems Earnings Call Transcript: Q4 2025
Margins and profitability improved in Q4 and full-year 2025, with recurring consumables revenue showing resilience despite macro headwinds. 2026 is set as an execution year, with growth expected to resume in 2027 as operational initiatives and innovation take effect.
BeautyHealth Reports Full Year and Fourth Quarter 2025 Financial Results
LONG BEACH, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth” or the "Company"), home to flagship brand Hydrafacial, today announced financial results...
Beauty Health announces ‘growing adoption’ of SkinStylus Nano-Channeling
The Beauty Health (SKIN) Company announced the expansion of its professional skin health ecosystem through growing adoption of its Hydrafacial treatments and SkinStylus Nano-Channeling combination pro...
BeautyHealth to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026
LONG BEACH, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report fourth quarter and full year 2025 fin...
Beauty Health price target raised to $1.65 from $1.50 at TD Cowen
TD Cowen analyst Oliver Chen raised the firm’s price target on Beauty Health (SKIN) to $1.65 from $1.50 and keeps a Hold rating on the shares. The firm adjusted targets…
Beauty Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of The Beauty Health Company - SKIN
NEW YORK and NEW ORLEANS, Jan. 20, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.
Beauty Health assumed with a Hold at Jefferies
Jefferies assumed coverage of Beauty Health (SKIN) with a Hold rating and $1.60 price target while taking over specialty softlines. Revisiting the 2026 outlook with a sharper lens on how…
HALPER SADEH LLC ENCOURAGES THE BEAUTY HEALTH COMPANY SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK , Dec. 5, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is invest...
SkinHealth Systems Earnings Call Transcript: Q3 2025
Q3 net sales declined 10.3% year-over-year to $70.7M, with device sales down 24.6% and consumables down 2.6%, but adjusted EBITDA rose 11% to $8.9M. Full-year guidance was raised, and the company is focusing on core consumables, innovation, and operational discipline.
BeautyHealth Appoints Philippe Schaison, PharmaD, to Board of Directors
LONG BEACH, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- The BeautyHealth Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced the appointment of global aesthetics leader, Philippe...
Halper Sadeh LLC Encourages The Beauty Health Company Shareholders to Contact the Firm to Discuss Their Rights
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of The Beauty Health Company (NASDAQ: SKIN) breached their fiduciary d...
BeautyHealth to Report Third Quarter 2025 Financial Results on November 6, 2025
The Beauty Health Company will report third quarter 2025 financial results on November 6, and host conference call and webcast at 4:30 p.m. ET that day.
Beauty Health appoints Pedro Malha CEO
The Beauty Health (SKIN) Company, home to flagship brand Hydrafacial, announced the appointment of Pedro Malha as president and CEO, effective October 1. He succeeds Marla Beck, who is stepping…
The Beauty Health Company Names Pedro Malha President and Chief Executive Officer
Global Healthcare and Medical Device Executive with More Than 20 Years of Experience Assumes Role Effective October 1 Marla Beck Steps Down, With BeautyHealth Prepared for Its Next Phase of Growth LON...
Hydrafacial Joins Cosmopolitan Readers' Choice Hall of Fame as Three-Time Winner for Best Pro Facial
This accolade builds on a year of major awards, reinforcing Hydrafacial's proven results and trusted position with consumers and providers worldwide This accolade builds on a year of major awards, rei...
Beauty Health price target raised to $2.50 from $2 at TD Cowen
TD Cowen analyst Oliver Chen raised the firm’s price target on Beauty Health (SKIN) to $2.50 from $2 and keeps a Hold rating on the shares. The firm believes the…
Beauty Health initiated with a Buy at Roth Capital
Roth Capital analyst George Kelly initiated coverage of Beauty Health (SKIN) with a Buy rating and $3.50 price target The firm is positive on the company’s turnaround efforts and believes…